photo of Prof Julie Bines

Prof Julie Bines

Prof Julie Bines

Details

Role Group Leader / Snr Princ Research Fellow

Contact

Professor Julie Bines leads the Enteric Diseases Group at Murdoch Children's Research Institute (MCRI). Professor Bines is the Victor and Loti Smorgon Professor of Paediatrics at the University of Melbourne and and a Paediatric Gastroenterologist and Clinical Nutrition Consultant at The Royal Children’s Hospital (RCH).

Professor Bines has led the development of the human neonatal rotavirus vaccine, RV3-BB vaccine, aimed at preventing rotavirus disease from birth in infants worldwide, including the clinical trials of RV3-BB vaccine in Australia, New Zealand, Indonesia and Malawi. The RV3-BB rotavirus vaccine is licensed to developing country vaccine manufacturers with the aim to manufacture an affordable oral rotavirus vaccine aimed to prevent rotavirus disease from birth, particularly in high child mortality regions.

Professor Bines is Director of the WHO Collaborative Centre for Child Health and the WHO Rotavirus Regional Reference Laboratory for the Western Pacific Region. She was the recipient of the 2021 Eureka Prize for Infectious Diseases Research and the 2023 Roger Glass Award for Excellence in Rotavirus Research. In 2021 she was elected to the Australian Academy of Health and Medical Sciences.
Professor Julie Bines leads the Enteric Diseases Group at Murdoch Children's Research Institute (MCRI). Professor Bines is the Victor and Loti Smorgon Professor of Paediatrics at the University of Melbourne and and a Paediatric Gastroenterologist and...
Professor Julie Bines leads the Enteric Diseases Group at Murdoch Children's Research Institute (MCRI). Professor Bines is the Victor and Loti Smorgon Professor of Paediatrics at the University of Melbourne and and a Paediatric Gastroenterologist and Clinical Nutrition Consultant at The Royal Children’s Hospital (RCH).

Professor Bines has led the development of the human neonatal rotavirus vaccine, RV3-BB vaccine, aimed at preventing rotavirus disease from birth in infants worldwide, including the clinical trials of RV3-BB vaccine in Australia, New Zealand, Indonesia and Malawi. The RV3-BB rotavirus vaccine is licensed to developing country vaccine manufacturers with the aim to manufacture an affordable oral rotavirus vaccine aimed to prevent rotavirus disease from birth, particularly in high child mortality regions.

Professor Bines is Director of the WHO Collaborative Centre for Child Health and the WHO Rotavirus Regional Reference Laboratory for the Western Pacific Region. She was the recipient of the 2021 Eureka Prize for Infectious Diseases Research and the 2023 Roger Glass Award for Excellence in Rotavirus Research. In 2021 she was elected to the Australian Academy of Health and Medical Sciences.

Top Publications

  • . Enteral Access. 174 -185 2026
    view publication
  • Tosif, S, Neeland, M, Sutton, P, Licciardi, P, Sarkar, S, Selva, K, Do, LAH, Donato, C, Toh, ZQ, Higgins, R, et al. Immune responses to SARS-CoV-2 in children of parents with symptomatic COVID-19. 2026
    view publication
  • Thobari, JA, Satria, C, Johanes, K, Haposan, JH, Watts, E, Standish, J, Handley, A, Bachtiar, N, Bines, J, Soenarto, Y. Intravenous Fluid Use in an Indonesian Community Cohort 0-18 Months of Age. 2026
    view publication
  • Licciardi, P, Wurzel, D, Neeland, M, Anderson, J, Abo, Y-N, Do, LAH, Donato, C, Bines, J, Toh, ZQ, Higgins, R, et al. Immune Responses in an Infant with Congenital Heart Disease and Severe COVID-19. 2026
    view publication
  • Toh, ZQ, Anderson, J, Mazarakis, N, Neeland, M, Higgins, RA, Rautenbacher, K, Dohle, K, Nguyen, J, Overmars, I, Donato, C, et al. Reduced seroconversion in children compared to adults with mild COVID-19. 2026
    view publication

Page 1 of 39

Career information